Delivery Order SPE2DB20D6035-SPE2DB24FD2BL
- Not listed
- This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The $1,297.41 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024. The contract has an ultimate completion date of November 1, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,136.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Atropine 0.4 mg/mL, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,194.31, is a Delivery Order for the supply of ATROPINE 1 MG/10ML 10S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Atropine 1 mg/ml vials, a critical medical commodity, with a ceiling value of $1,717.40 and a period of performance through October 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,346.08 and is for the delivery of ATROPINE 1 MG/ML VIAL. The contract is a Firm Fixed Price, non-set-aside contract with a performance period extending through May 30, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This $1,567.17 federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,172.34 firm fixed price delivery order is for the supply of 8 mg/20 ml vials of the medication Atropine. The contract has a completion date of July 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,459.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $5,370.26, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4564680952 ATROPINE 1 MG/ML VIALML, a critical pharmaceutical product, with a performance period extending until May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded several federal contracts to supply a wide range of...
- This federal contract award to Amerisourcebergen Drug Corp, the prime contractor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,715.33, is a Firm Fixed Price Delivery Order for the supply of Atropine 1 mg/ml vials. This contract is not set aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) with various federal agencies, including the DLA Troop Support Medical and the...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD2BLDelivery Order
This federal contract award is for the delivery of Atropine 8 mg/20 ml vials to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and healthcare solutions. The contract has a ceiling value of $1,100.08 and a completion date of April 29, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/26/24 |